Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Case report

Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab

Online download statistics by month:

Online download statistics by month: January 2022 to April 2024

	Abstract	Full	Pdf
Jan 2022	328	331	159
Feb 2022	376	378	105
Mar 2022	206	212	40
Apr 2022	175	181	46
May 2022	146	154	59
Jun 2022	105	106	35
Jul 2022	94	94	32
Aug 2022	130	129	21
Sep 2022	155	156	38
Oct 2022	138	138	39
Nov 2022	136	137	23
Dec 2022	115	111	30
Jan 2023	117	119	38
Feb 2023	122	119	37
Mar 2023	134	132	33
Apr 2023	108	108	22
May 2023	115	110	25
Jun 2023	133	131	31
Jul 2023	116	111	21
Aug 2023	123	123	27
Sep 2023	154	147	35
Oct 2023	101	100	30
Nov 2023	130	126	28
Dec 2023	113	112	25
Jan 2024	27	27	11
Feb 2024	77	75	25
Mar 2024	154	146	49
Apr 2024	72	69	13
Total	3900	3882	1077